CD8A and neoplasm: Low pH (6.5–6.9) is adverse to anti-tumor immunity, where effector CD8+T cells exhibit reduced IL-2Rα (CD25) and TCR expression, along with STAT5 and extracellular signal-regulated kinase (ERK) inactivation (Calcinotto et al., 2012).